These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15561919)

  • 1. Prevention of type 2 diabetes: insulin resistance and beta-cell function.
    Chiasson JL; Rabasa-Lhoret R
    Diabetes; 2004 Dec; 53 Suppl 3():S34-8. PubMed ID: 15561919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus.
    Kahn SE
    Am J Med; 2000 Apr; 108 Suppl 6a():2S-8S. PubMed ID: 10764844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose.
    Abdul-Ghani MA; Tripathy D; DeFronzo RA
    Diabetes Care; 2006 May; 29(5):1130-9. PubMed ID: 16644654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of troglitazone on insulin sensitivity and pancreatic beta-cell function in women at high risk for NIDDM.
    Berkowitz K; Peters R; Kjos SL; Goico J; Marroquin A; Dunn ME; Xiang A; Azen S; Buchanan TA
    Diabetes; 1996 Nov; 45(11):1572-9. PubMed ID: 8866563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin secretion and anti-GAD65 antibodies in subjects with impaired glucose tolerance.
    Tankova T; Dakovska L; Kirilov G; Koev D
    Exp Clin Endocrinol Diabetes; 2001; 109(7):355-60. PubMed ID: 11573145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic beta-cell function and insulin sensitivity in japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus.
    Kanauchi M; Nakajima M; Saito Y; Kanauchi K
    Metabolism; 2003 Apr; 52(4):476-81. PubMed ID: 12701062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.
    Kitabchi AE; Temprosa M; Knowler WC; Kahn SE; Fowler SE; Haffner SM; Andres R; Saudek C; Edelstein SL; Arakaki R; Murphy MB; Shamoon H;
    Diabetes; 2005 Aug; 54(8):2404-14. PubMed ID: 16046308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For debate: Starling's curve of the pancreas--overuse of a concept?
    Stumvoll M; Häring H; Fritsche A
    Horm Metab Res; 2003 Jul; 35(7):391-5. PubMed ID: 12931268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.
    Weyer C; Tataranni PA; Bogardus C; Pratley RE
    Diabetes Care; 2001 Jan; 24(1):89-94. PubMed ID: 11194248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
    Viswanathan V; Clementina M; Nair BM; Satyavani K
    J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1).
    Snehalatha C; Mary S; Selvam S; Sathish Kumar CK; Shetty SB; Nanditha A; Ramachandran A
    Diabetes Care; 2009 Oct; 32(10):1796-801. PubMed ID: 19587369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.
    Retnakaran R; Shen S; Hanley AJ; Vuksan V; Hamilton JK; Zinman B
    Obesity (Silver Spring); 2008 Aug; 16(8):1901-7. PubMed ID: 18551118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between insulin resistance and insulin secretion in the development of glucose intolerance.
    Cavaghan MK; Ehrmann DA; Polonsky KS
    J Clin Invest; 2000 Aug; 106(3):329-33. PubMed ID: 10930434
    [No Abstract]   [Full Text] [Related]  

  • 16. Predominant role of reduced beta-cell sensitivity to glucose over insulin resistance in impaired glucose tolerance.
    Ferrannini E; Gastaldelli A; Miyazaki Y; Matsuda M; Pettiti M; Natali A; Mari A; DeFronzo RA
    Diabetologia; 2003 Sep; 46(9):1211-9. PubMed ID: 12879253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.
    Kahn SE
    Diabetologia; 2003 Jan; 46(1):3-19. PubMed ID: 12637977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.
    Buchanan TA; Xiang AH; Peters RK; Kjos SL; Marroquin A; Goico J; Ochoa C; Tan S; Berkowitz K; Hodis HN; Azen SP
    Diabetes; 2002 Sep; 51(9):2796-803. PubMed ID: 12196473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.
    Scheen AJ
    Drugs; 2004; 64(22):2537-65. PubMed ID: 15516153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.